Contamac Ltd, founded in 1987, stands at the forefront of the ophthalmic industry. Renowned globally, the company specializes in the creation of advanced biocompatible materials used in contact lenses and intraocular lenses. Their expertise lies in the development of specialist polymers, essential for eye correction technologies worldwide.
Operating out of a state-of-the-art laboratory in Saffron Walden, England, Contamac serves a dual role in the Health Care and Manufacturing industries. This positions them uniquely to leverage their material technology expertise for medical applications.
Their last noted investment was a €330.00K grant in February 2012. Though past funding was limited, their long-standing industry presence and specialization present a compelling opportunity for investors aiming to capitalize on innovation in biocompatible materials.